<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5751318</article-id><article-id pub-id-type="doi">10.3390/ijms18122717</article-id><article-id pub-id-type="publisher-id">ijms-18-02717</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Fibrinogen Gamma Chain Mutations Provoke Fibrinogen and Apolipoprotein B Plasma Deficiency and Liver Storage </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Callea</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="af1-ijms-18-02717">1</xref><xref rid="c1-ijms-18-02717" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Giovannoni</surname><given-names>Isabella</given-names></name><xref ref-type="aff" rid="af1-ijms-18-02717">1</xref></contrib><contrib contrib-type="author"><name><surname>Sari</surname><given-names>Sinan</given-names></name><xref ref-type="aff" rid="af2-ijms-18-02717">2</xref></contrib><contrib contrib-type="author"><name><surname>Guldal</surname><given-names>Esendagli</given-names></name><xref ref-type="aff" rid="af3-ijms-18-02717">3</xref></contrib><contrib contrib-type="author"><name><surname>Dalgic</surname><given-names>Buket</given-names></name><xref ref-type="aff" rid="af2-ijms-18-02717">2</xref></contrib><contrib contrib-type="author"><name><surname>Akyol</surname><given-names>Gulen</given-names></name><xref ref-type="aff" rid="af3-ijms-18-02717">3</xref></contrib><contrib contrib-type="author"><name><surname>Sogo</surname><given-names>Tsuyoshi</given-names></name><xref ref-type="aff" rid="af4-ijms-18-02717">4</xref></contrib><contrib contrib-type="author"><name><surname>Al-Hussaini</surname><given-names>Abdulrahman</given-names></name><xref ref-type="aff" rid="af5-ijms-18-02717">5</xref></contrib><contrib contrib-type="author"><name><surname>Maggiore</surname><given-names>Giuseppe</given-names></name><xref ref-type="aff" rid="af6-ijms-18-02717">6</xref></contrib><contrib contrib-type="author"><name><surname>Bartuli</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="af7-ijms-18-02717">7</xref></contrib><contrib contrib-type="author"><name><surname>Boldrini</surname><given-names>Renata</given-names></name><xref ref-type="aff" rid="af1-ijms-18-02717">1</xref></contrib><contrib contrib-type="author"><name><surname>Francalanci</surname><given-names>Paola</given-names></name><xref ref-type="aff" rid="af1-ijms-18-02717">1</xref></contrib><contrib contrib-type="author"><name><surname>Bellacchio</surname><given-names>Emanuele</given-names></name><xref ref-type="aff" rid="af8-ijms-18-02717">8</xref></contrib></contrib-group><aff id="af1-ijms-18-02717"><label>1</label>Department Pathology and Molecular Histopathology, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; <email>isabella.giovannoni@opbg.net</email> (I.G.); <email>renata.boldrini@opbg.net</email> (R.B.); <email>paola.francalanci@opbg.net</email> (P.F.)</aff><aff id="af2-ijms-18-02717"><label>2</label>Department Pediatric Gastroenterology, Gazi University Ankara, 06560 Ankara, Turkey; <email>drsinansari@gmail.com</email> (S.S.); <email>buketdalgic@gmail.com</email> (B.D.)</aff><aff id="af3-ijms-18-02717"><label>3</label>Department Pathology, Gazi University Ankara, 06560 Ankara, Turkey; <email>drguldal@yahoo.com</email> (E.G.); <email>gulenakyol@yahoo.com</email> (G.A.)</aff><aff id="af4-ijms-18-02717"><label>4</label>Department of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohama City Tobu Hospital 3-6-1, Shimosueyoshi, Tsurumi Ward, Yokohama City, Kanagawa, Japan; <email>so5244ibukick@kdp.biglobe.ne.jp</email></aff><aff id="af5-ijms-18-02717"><label>5</label>Division of Pediatric Gastroenterology, Children's Specialized Hospital, King Fahad Medical City, College of Medicine, Alfaisal University Riyadh 11525, Saudi Arabia; <email>aa_alhussaini@yahoo.com</email></aff><aff id="af6-ijms-18-02717"><label>6</label>Section of Pediatrics, Department of Medical Sciences, University of Ferrara, University Hospital Arcispedale Sant’Anna, 44100 Ferrara, Italy; <email>giuseppe.maggiore@unife.it</email></aff><aff id="af7-ijms-18-02717"><label>7</label>Rare Disease and Medical Genetics, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; <email>andrea.bartuli@opbg.net</email></aff><aff id="af8-ijms-18-02717"><label>8</label>Genetics and Rare Diseases, Research Division, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, Italy; <email>emanuele.bellacchio@opbg.net</email></aff><author-notes><corresp id="c1-ijms-18-02717"><label>*</label>Correspondence: <email>francesco.callea@opbg.net</email>; Tel.: +39-06-6859-2818; Fax: +39-06-6859-2036</corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2017</year></pub-date><volume>18</volume><issue>12</issue><elocation-id>2717</elocation-id><history><date date-type="received"><day>06</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>13</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>© 2017 by the authors.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>p.R375W (Fibrinogen Aguadilla) is one out of seven identified mutations (Brescia, Aguadilla, Angers, Al du Pont, Pisa, Beograd, and Ankara) causing hepatic storage of the mutant fibrinogen γ. The Aguadilla mutation has been reported in children from the Caribbean, Europe, Japan, Saudi Arabia, Turkey, and China. </plain></SENT>
<SENT sid="3" pm="."><plain>All reported children presented with a variable degree of histologically proven chronic liver disease and low plasma fibrinogen levels. </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, one Japanese and one Turkish child had concomitant hypo-APOB-lipoproteinemia of unknown origin. </plain></SENT>
<SENT sid="5" pm="."><plain>We report here on an additional child from Turkey with hypofibrinogenemia due to the Aguadilla mutation, massive hepatic storage of the mutant protein, and severe hypo-APOB-lipoproteinemia. </plain></SENT>
<SENT sid="6" pm="."><plain>The liver biopsy of the patient was studied by light microscopy, electron microscopy (EM), and immunohistochemistry. </plain></SENT>
<SENT sid="7" pm="."><plain>The investigation included the DNA sequencing of the three fibrinogen and APOB–lipoprotein regulatory genes and the analysis of the encoded protein structures. </plain></SENT>
<SENT sid="8" pm="."><plain>Six additional Fibrinogen Storage Disease (FSD) patients with either the Aguadilla, Ankara, or Brescia mutations were investigated with the same methodology. </plain></SENT>
<SENT sid="9" pm="."><plain>A molecular analysis revealed the fibrinogen gamma p.R375W mutation (Aguadilla) but no changes in the APOB and MTTP genes. APOB and MTTP genes showed no abnormalities in the other study cases. </plain></SENT>
<SENT sid="10" pm="."><plain>Light microscopy and EM studies of liver tissue samples from the child led to the demonstration of the simultaneous accumulation of both fibrinogen and APOB in the same inclusions. </plain></SENT>
<SENT sid="11" pm="."><plain>Interestingly enough, APOB-containing lipid droplets were entrapped within the fibrinogen inclusions in the hepatocytic Endoplasmic Reticulum (ER). </plain></SENT>
<SENT sid="12" pm="."><plain>Similar histological, immunohistochemical, EM, and molecular genetics findings were found in the other six FSD cases associated with the Aguadilla, as well as with the Ankara and Brescia mutations. </plain></SENT>
<SENT sid="13" pm="."><plain>The simultaneous retention of fibrinogen and APOB-lipoproteins in FSD can be detected in routinely stained histological sections. </plain></SENT>
<SENT sid="14" pm="."><plain>The analysis of protein structures unraveled the pathomorphogenesis of this unexpected phenomenon. </plain></SENT>
<SENT sid="15" pm="."><plain>Fibrinogen gamma chain mutations provoke conformational changes in the region of the globular domain involved in the “end-to-end” interaction, thus impairing the D-dimer formation. </plain></SENT>
<SENT sid="16" pm="."><plain>Each monomeric fibrinogen gamma chain is left with an abnormal exposure of hydrophobic patches that become available for interactions with APOB and lipids, causing their intracellular retention and impairment of export as a secondary unavoidable phenomenon. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>Fibrinogen Storage Disease</kwd><kwd>APOB-lipoprotein</kwd><kwd>Endoplasmic Reticulum Storage Disease</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec id="sec1-ijms-18-02717"><title><text><SENT sid="17" pm="."><plain>1. </plain></SENT>
<SENT sid="18" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="19" pm="."><plain>Hereditary Hypofibrinogenemia (HH) with hepatic storage of fibrinogen was identified as an Endoplasmic Reticulum Storage Disease (ERSD) in 1987 in an Italian patient [1]. </plain></SENT>
<SENT sid="20" pm="."><plain>Initially, the entity was accepted with skepticism by fibrinogen experts not only because of its unusual clinical presentation, i.e., hypofibrinogenemia in the absence of overt dysfibrinogenemia, coagulation, or thrombosis manifestations, but also because of its unexpected pathogenesis, i.e., plasma deficiency secondary to a defective export and consequential storage [2]. </plain></SENT>
<SENT sid="21" pm="."><plain>The final proof that HH with hepatic storage represented a new ERSD was obtained by demonstrating that the retention phenomenon observed in the original Italian patient [1] was due to the p.G284R mutation in the fibrinogen γ chain [3]. </plain></SENT>
</text></p><p><text><SENT sid="22" pm="."><plain>The discovery of the new entity revealed the etiology of a disease, fibrinogen storage disease (FSD) [4], that otherwise would have remained cryptogenic, in analogy to the α-1-antitrypsin (AAT) deficiency (AATD) [2]. </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>Since then, six fibrinogen mutant variants were described: Aguadilla p.R375W [5], Angers p.del372-376 [6], Al DuPont p.T314P [7], Pisa p.D316N [8], Beograd p.G366S [8], and Ankara p.H340D [9]. </plain></SENT>
</text></p><p><text><SENT sid="24" pm="."><plain>All variants were detected by morphological examination of liver tissue specimens obtained for unexplained liver disease. </plain></SENT>
<SENT sid="25" pm="."><plain>All reported cases displayed cytoplasmic inclusions in hepatocytes by light microscopy, which reacted positively for fibrinogen, and a characteristic fingerprint-like appearance of the stored fibrinogen by Electron Microscopy (EM) [1,2,3]. </plain></SENT>
</text></p><p><text><SENT sid="26" pm="."><plain>Among the reported FSD cases, two children with the Aguadilla mutation presented with hypofibrinogenemia and hypo-apo-β (APOB)-lipoproteinemia [10,11]. </plain></SENT>
<SENT sid="27" pm="."><plain>In one of the two cases [11], the molecular analysis of the APOB and Microsomal Triglyceride Transporter Protein (MTTP) genes, which are responsible for lipid transfer and assembly, revealed no abnormalities, thus the low plasma levels of APOB lipoproteins remained unexplained. </plain></SENT>
</text></p><p><text><SENT sid="28" pm="."><plain>Recently, we came across an additional child with the Aguadilla mutation presenting with hypofibrinogenemia associated with hypo-APOB-lipoproteinemia. </plain></SENT>
<SENT sid="29" pm="."><plain>The recurrence of this association urged us to set up an extensive investigation on this novel Aguadilla case and a retrospective study on the available material from all FSD cases from our files, collected during the period 1987–2017 and including four additional Aguadilla, 1 Ankara, and 1 Brescia cases. </plain></SENT>
</text></p><p><text><SENT sid="30" pm="."><plain>The combination of histology, immunohistochemistry, EM, molecular analysis, and 3-D protein structure studies clarified the pathogenetic mechanism of this intriguing association. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS"><sec id="sec2-ijms-18-02717"><title><text><SENT sid="31" pm="."><plain>2. </plain></SENT>
<SENT sid="32" pm="."><plain>Results </plain></SENT>
</text></title><sec id="sec2dot1-ijms-18-02717"><title><text><SENT sid="33" pm="."><plain>2.1. </plain></SENT>
<SENT sid="34" pm="."><plain>Proband </plain></SENT>
</text></title><sec id="sec2dot1dot1-ijms-18-02717"><title><text><SENT sid="35" pm="."><plain>2.1.1. </plain></SENT>
<SENT sid="36" pm="."><plain>Morphological Studies </plain></SENT>
</text></title><p><text><SENT sid="37" pm="."><plain>The histological examination of liver tissue sections revealed a preserved lobular architecture with a mild expansion of portal tracts and an occasional portal–portal septum. </plain></SENT>
<SENT sid="38" pm="."><plain>A mild lymphocytic infiltration was present in a minority of portal tracts without spillover into the parenchyma. </plain></SENT>
<SENT sid="39" pm="."><plain>Nearly 100% of the hepatocytes contained round or polygonal eosinophilic inclusions filling up the entire cytoplasm (Figure 1A). </plain></SENT>
<SENT sid="40" pm="."><plain>At times, the inclusions were surrounded by a clear halo and often centered by lipid vacuoles that could be single or in clusters (Figure 1A). </plain></SENT>
<SENT sid="41" pm="."><plain>Both fibrinogen globules and intraglobular lipids were negative on Periodic Acid Schiff reaction (PAS) or PAS after diastase digestion (PAS-D) staining. </plain></SENT>
<SENT sid="42" pm="."><plain>A mild degree of microvescicular steatosis was present in several hepatocytes. </plain></SENT>
</text></p></sec><sec id="sec2dot1dot2-ijms-18-02717"><title><text><SENT sid="43" pm="."><plain>2.1.2. </plain></SENT>
<SENT sid="44" pm="."><plain>Immunohistochemistry </plain></SENT>
</text></title><p><text><SENT sid="45" pm="."><plain>All eosinophilic cytoplasmic inclusions stained positively for fibrinogen and were negative for AAT and α-1-antichymotrypsin, thus indicating a selective and exclusive retention of fibrinogen [2]. </plain></SENT>
<SENT sid="46" pm="."><plain>The staining for IgG was negative, thus excluding the possibility of a passive inflow of plasma proteins [12]. </plain></SENT>
<SENT sid="47" pm="."><plain>The intraglobular lipid vacuoles were positively stained with an APOB specific antibody. </plain></SENT>
<SENT sid="48" pm="."><plain>The positivity was quite strong and localized at the periphery of the vacuoles (Figure 1C). </plain></SENT>
<SENT sid="49" pm="."><plain>In double immunostained preparations, the APOB immunoreactive material could be visualized within individual fibrinogen-positive inclusions (Figure 1E). </plain></SENT>
</text></p><p><text><SENT sid="50" pm="."><plain>Sections from patients with no mutations in the FGG (i.e., without fibrinogen inclusions) were negative when stained with the two antibodies. </plain></SENT>
<SENT sid="51" pm="."><plain>Likewise, the sections from the case series remained equally negative when the primary antibodies against the two proteins were omitted. </plain></SENT>
</text></p></sec><sec id="sec2dot1dot3-ijms-18-02717"><title><text><SENT sid="52" pm="."><plain>2.1.3. </plain></SENT>
<SENT sid="53" pm="."><plain>Electron Microscopy </plain></SENT>
</text></title><p><text><SENT sid="54" pm="."><plain>Under the EM, the fibrinogen globular inclusions corresponded to dilated ER cisternae filled up with densely packed tubular structures arranged in curved bundles, resulting in a fingerprint-like appearance (Figure 1B). </plain></SENT>
<SENT sid="55" pm="."><plain>A majority of fibrinogen globules contained single or multiple lipid inclusions (Figure 1B,D). </plain></SENT>
<SENT sid="56" pm="."><plain>Nonmembrane-bound lipid droplets were observed within the cytoplasm. </plain></SENT>
</text></p></sec><sec id="sec2dot1dot4-ijms-18-02717"><title><text><SENT sid="57" pm="."><plain>2.1.4. </plain></SENT>
<SENT sid="58" pm="."><plain>Molecular Genetics Analysis </plain></SENT>
</text></title><p><text><SENT sid="59" pm="."><plain>Sequencing analysis of the FGA, FGB, APOB, MTTP genes coding regions and splice sites did not reveal mutations; FGG analysis showed the p.R375W (Aguadilla mutation) in a heterozygous status. </plain></SENT>
<SENT sid="60" pm="."><plain>The genotype of other study cases is reported in Table 1. </plain></SENT>
</text></p></sec><sec id="sec2dot1dot5-ijms-18-02717"><title><text><SENT sid="61" pm="."><plain>2.1.5. </plain></SENT>
<SENT sid="62" pm="."><plain>Structural Analysis </plain></SENT>
</text></title><p><text><SENT sid="63" pm="."><plain>The analysis of the crystal structure of human fibrinogen fragment D (PDB 1FZB) showed that the Aguadilla, Ankara, and Brescia mutations fall nearby the regions exploited by the globular domains of two γ chains in their “end-to-end” interaction necessary for the D dimer formation, and also that these regions feature patches of hydrophobic residues that normally remain hidden upon correct dimerization (Figure 2). </plain></SENT>
</text></p><p><text><SENT sid="64" pm="."><plain>Patches of hydrophobic residues are also present in the lipid-binding region of APOB, as it can be observed by examining the homology model of APOB by Richardson et al. [13] and also in the crystal structure of lipovitellin (PDB 1LSH), which is the closest homologue of APOB with a known folding (Figure 3). </plain></SENT>
</text></p></sec><sec id="sec2dot1dot6-ijms-18-02717"><title><text><SENT sid="65" pm="."><plain>2.1.6. </plain></SENT>
<SENT sid="66" pm="."><plain>Retrospective Analysis </plain></SENT>
</text></title><p><text><SENT sid="67" pm="."><plain>The review of histological and ultrathin sections from the six previously reported FSD cases led to the identification of lipid droplets within the fibrinogen inclusions at both light microscopy and EM levels. </plain></SENT>
<SENT sid="68" pm="."><plain>Lipid inclusions were not mentioned in previous FSD case reports, except in the Fibrinogen Brescia case [1,3]. </plain></SENT>
<SENT sid="69" pm="."><plain>We reviewed the original ultrathin sections from this case and confirmed the presence of lipid inclusions within the aggregated fibrinogen in the ER (Figure 1F). </plain></SENT>
</text></p><p><text><SENT sid="70" pm="."><plain>The main clinical and biochemical results from the study series are summarized in Table 1. </plain></SENT>
</text></p><p><text><SENT sid="71" pm="."><plain>Table 2 summarizes all confirmed cases of FSD in the literature. </plain></SENT>
</text></p></sec></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="sec3-ijms-18-02717"><title><text><SENT sid="72" pm="."><plain>3. </plain></SENT>
<SENT sid="73" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="74" pm="."><plain>This study demonstrated that in FSD due to Aguadilla, Ankara, and Brescia mutations the mutant fibrinogen is retained within the ER in the form of round or polygonal eosinophilic PAS-D-negative inclusions which contain in their inside single or multiple lipid droplets. </plain></SENT>
<SENT sid="75" pm="."><plain>The lipid droplets correspond to APOB lipoprotein and other lipids. </plain></SENT>
<SENT sid="76" pm="."><plain>The colocalization of the two components in the same inclusion bodies was confirmed by a double immunostaining technique with the sequential application of an anti-fibrinogen and an anti-APOB lipoprotein antibody on the same liver tissue section. </plain></SENT>
<SENT sid="77" pm="."><plain>The positivity for APOB was mainly located at the circumferential periphery of the lipid inclusions, whose central empty part corresponded to lipids which were dissolved by solvent agents during the preparation processes. </plain></SENT>
<SENT sid="78" pm="."><plain>Under the EM, the lipid droplets appeared entrapped within the net of curved fingerprint-like tubular structures corresponding to fibrinogen that aggregated within the ER. </plain></SENT>
</text></p><p><text><SENT sid="79" pm="."><plain>The first point to bring into the discussion is the molecular profile of the regulatory genes of APOB lipoproteins. </plain></SENT>
</text></p><p><text><SENT sid="80" pm="."><plain>Interestingly, the molecular genetic analysis of the two genes, APOB and MTTP, which are involved in the transfer of triglycerides, assembly, and transport of APOB-containing lipoproteins, failed to demonstrate any mutation in these genes in our FSD cases. </plain></SENT>
<SENT sid="81" pm="."><plain>These results led to the conclusion that the hypo-APOB-lipoproteinemia associated with hypofibrinogenemia does not fit into the spectrum of hereditary a-betalipoproteinemia (OMIM# 200100). </plain></SENT>
<SENT sid="82" pm="."><plain>The latter is an autosomal recessive disorder characterized by the virtual absence of VLDL and LDL from plasma [20]. </plain></SENT>
<SENT sid="83" pm="."><plain>In this disorder, the failure of secretion of VLDL points to defects in the processing of the APOB proteins or to an impairment of the assembly or secretion of triglyceride-rich lipoproteins. </plain></SENT>
<SENT sid="84" pm="."><plain>The molecular defect was identified in the absence of activity of MTTP, a factor critical to lipidation of APOB. </plain></SENT>
</text></p><p><text><SENT sid="85" pm="."><plain>In familial hypo-beta-lipoproteinemia (FHBL) (OMIM# 107730), a genetic heterogeneous autosomal codominant disorder [21], defects of APOB genes are involved in most cases, leading to the formation of prematurely truncated APOB species. </plain></SENT>
<SENT sid="86" pm="."><plain>However, a number of defects affecting the rate of synthesis or the rate of removal of APOB is also emerging [21]. </plain></SENT>
</text></p><p><text><SENT sid="87" pm="."><plain>The second point to bring into discussion is the colocalization of the two proteins (the abnormal fibrinogen and the normal APOB) in the same ER inclusions. </plain></SENT>
<SENT sid="88" pm="."><plain>This finding is in congruence with the low plasma levels of both proteins. </plain></SENT>
</text></p><p><text><SENT sid="89" pm="."><plain>The third point raises the question about the primary event in the storage process. </plain></SENT>
</text></p><p><text><SENT sid="90" pm="."><plain>The mutations affecting Aguadilla, Ankara, and Brescia are located in the globular domain of the gamma chain, nearby the region of the “end-to-end” interaction that involves two of these molecules in the formation of the D dimer. </plain></SENT>
<SENT sid="91" pm="."><plain>Mutations located on the D–D interaction surface are capable of resulting in a defective polymerization of fibrinogen [22]. </plain></SENT>
</text></p><p><text><SENT sid="92" pm="."><plain>The molecular genetics results from our study definitely ruled out the possibility that APOB lipoproteinemia in FSD was due to genetic reasons, thus we focused on the possible involvement of defective fibrinogen gamma chains in APOB deficiency. </plain></SENT>
<SENT sid="93" pm="."><plain>As a matter of fact, the globular domain of the fibrinogen γ chain contains patches of hydrophobic residues that are exploited in the formation of the D dimer and therefore remain hidden upon correct polymerization. </plain></SENT>
<SENT sid="94" pm="."><plain>The γ chain mutations are expected to induce important changes at the site of D–D interactions. </plain></SENT>
<SENT sid="95" pm="."><plain>This can affect the D–D dimerization, causing the hydrophobic patches to remain abnormally exposed towards the external milieu and available for undue interactions with other molecules in the ER lumen. </plain></SENT>
<SENT sid="96" pm="."><plain>With regard to the presence of lipid droplets within the fibrinogen inclusions, we can assume that the overexposed hydrophobic patches of particular γ chain mutations can bind APOB molecules, since the latter protein is characterized by large hydrophobic regions that are normally used for the transport of lipids. </plain></SENT>
<SENT sid="97" pm="."><plain>These hydrophobic features are highlighted in Figure 2, showing the arrangement of fibrinogen α, β, and γ chains and the D–D interface of two gamma chains in the fragment D from the PDB structure 1FZB [22], and in Figure 3 showing a fibrinogen gamma monomer from the previous structure, the homology model of APOB [13], and the crystal structure of the lamprey lipovitellin (PDB 1LSH) [23] that is the closest homologue of APOB with known folding. </plain></SENT>
</text></p><p><text><SENT sid="98" pm="."><plain>γ chain mutants anomalously bound to APOB may serve as nucleation centers for the formation of hydrophobic clusters. </plain></SENT>
<SENT sid="99" pm="."><plain>Above a critical concentration, the latter coalesce into a lipid phase that becomes visible in the form of lipid droplets at both light and ultrastructural levels. </plain></SENT>
</text></p><p><text><SENT sid="100" pm="."><plain>The reason why the lipid droplets appear empty under the light microscope is that most lipids (triglycerides, cholesterol, LDL cholesterol) disappear as a consequence of the detergent effect of the solvents used during tissue preparation. </plain></SENT>
<SENT sid="101" pm="."><plain>The APOB protein content, however, is preserved and can be visualized by immunohistochemistry by a specific antigen–antibody reaction. </plain></SENT>
<SENT sid="102" pm="."><plain>This mechanism explains our morphological observations in congruence with the known biochemical pathways. </plain></SENT>
<SENT sid="103" pm="."><plain>In fact, during the aggregation process of mutated fibrinogen molecules within the ER, lipid molecules transverse the ER membranes and translocate from the cytosol to the luminal cisternae together with other lipid components. </plain></SENT>
<SENT sid="104" pm="."><plain>Once there, they are sequestered by the abnormal monomeric fibrinogen gamma chains, which undergo aggregation. </plain></SENT>
</text></p><p><text><SENT sid="105" pm="."><plain>The assembly of lipoproteins containing APOB particles in our FSD cases would have no reasons to be hampered, as the assembly and secretion processes are physiologically regulated by microsomal-associated luminal lipid droplets [24], and these are regularly transferred from the cytosol to the ER when the responsible APOB and MTTP genes are normal. </plain></SENT>
</text></p><p><text><SENT sid="106" pm="."><plain>The mutant gamma chains are entirely retained as monomers in the ER [25] and never exported into the circulation in the Aguadilla [5], as well as Brescia mutations [3,24]. </plain></SENT>
</text></p><p><text><SENT sid="107" pm="."><plain>A fourth point for discussion is the link at the cellular level between basal fibrinogen expression and lipid metabolism. </plain></SENT>
<SENT sid="108" pm="."><plain>This represents a basic phenomenon in biology [26]. </plain></SENT>
<SENT sid="109" pm="."><plain>Indeed, it has been demonstrated that the increase of APOB runs parallel to the increased basal expression of fibrinogen and that the overexpression of fibrinogen is associated with increased APOB retention due to a diminished intracellular degradation [26]. </plain></SENT>
</text></p><p><text><SENT sid="110" pm="."><plain>In FSD, the low plasma levels of APOB can be sufficiently explained by APOB retention within the secretory pathway. </plain></SENT>
<SENT sid="111" pm="."><plain>The degradation of both APOB and misfolded fibrinogens follows the ubiquitination proteasome pathway [27,28], which requires dislocation and retrotranslocation of the aberrant proteins towards the cytoplasm with the cooperation of endoplasmic reticulum-associated degradation (ERAD) proteins. </plain></SENT>
<SENT sid="112" pm="."><plain>ERAD are found in association with cytoplasmic lipid degradation complexes [23,29]. </plain></SENT>
<SENT sid="113" pm="."><plain>In addition to the ERAD pathway, the excess of aggregated fibrinogen mutants is degraded via autophagy [16]. </plain></SENT>
</text></p><p><text><SENT sid="114" pm="."><plain>Recently, it was demonstrated that autophagy-enhancing drugs such as carbamazepine diminish hepatocellular death in both Aguadilla and Brescia FSD [16]. </plain></SENT>
<SENT sid="115" pm="."><plain>A normalization of transaminases was reported during a long-term follow-up in an Aguadilla child treated with ursodeoxycolic acid [30]. </plain></SENT>
<SENT sid="116" pm="."><plain>An incomplete response to both carbamazepine and ursodeoxycholic was more recently reported by Mei-Hong Zhang in a Chinese boy with a de novo Aguadilla mutation [19]. </plain></SENT>
</text></p><p><text><SENT sid="117" pm="."><plain>Considering that APOB and other lipids are unavoidably retained within the ER in FSD, one would expect that drugs or molecular interventions capable of reducing the amount of fibrinogen aggregation and storage would also result in a decrease of the amount of APOB and other lipids retention and consequently in their plasma level increase. </plain></SENT>
</text></p><p><text><SENT sid="118" pm="."><plain>This study has definitely proven that hereditary hypofibrinogenemia is due to fibrinogen gamma chain mutations and that the associated hypo-APOB-liproteinemia is a secondary phenomenon. </plain></SENT>
</text></p><p><text><SENT sid="119" pm="."><plain>Fibrinogen mutations can provoke conformational changes in the region of the globular domain involved in the “end-to-end” interaction, thus impairing the D dimer formation. </plain></SENT>
<SENT sid="120" pm="."><plain>Each monomeric fibrinogen gamma chain is left with an abnormal exposure of hydrophobic patches that become available for interaction with APOB, causing intracellular retention and impairment of export. </plain></SENT>
</text></p><p><text><SENT sid="121" pm="."><plain>The phenomenon results in unique morphological features consisting in lipid droplets within fibrinogen globules. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="sec4-ijms-18-02717"><title><text><SENT sid="122" pm="."><plain>4. </plain></SENT>
<SENT sid="123" pm="."><plain>Material and Methods </plain></SENT>
</text></title><p><text><SENT sid="124" pm="."><plain>The material of the study comprised a prospective patient (proband) (case n. 1, Table 1 and Table 3) and six retrospective cases from our files (cases n. 2–7, Table 1), which were suffering from hereditary hypofibrinogenemia and hepatic storage. </plain></SENT>
<SENT sid="127" pm="."><plain>All of them had already been published individually by us (see below, Retrospective studies). </plain></SENT>
</text></p><sec id="sec4dot1-ijms-18-02717"><title><text><SENT sid="128" pm="."><plain>4.1. </plain></SENT>
<SENT sid="129" pm="."><plain>Case History (Proband) </plain></SENT>
</text></title><p><text><SENT sid="130" pm="."><plain>A three-year-old female from Turkey, second born to nonconsanguineous parents by vaginal delivery at term. </plain></SENT>
<SENT sid="131" pm="."><plain>The parents and the brother were in good health. </plain></SENT>
<SENT sid="132" pm="."><plain>The birth weight was 2750 g. At age 5 months, the child was hospitalized for fever, and abnormal liver function tests were detected: AST 77 U/L (n.v. </plain></SENT>
<SENT sid="134" pm="."><plain>20–60), ALT 151 I/U (n.v. </plain></SENT>
<SENT sid="135" pm="."><plain>5–45), GGT 67 U/L (n.v. </plain></SENT>
<SENT sid="136" pm="."><plain>5–32). </plain></SENT>
<SENT sid="137" pm="."><plain>During a two years follow-up, the liver test remained abnormal. </plain></SENT>
<SENT sid="138" pm="."><plain>At the last follow-up physical examination, the patient presented hepatomegaly (3 cm below the right costal margin) and abnormal transaminases (AST 165 U/L, ALT 246 UL, GGT 71 U/L). </plain></SENT>
<SENT sid="139" pm="."><plain>The child also showed persistent low plasma fibrinogen levels (74 mg/dL; n.v. </plain></SENT>
<SENT sid="140" pm="."><plain>200–400) and low levels of APOB-lipoprotein (&lt;24.5 mg/dL; n.v. </plain></SENT>
<SENT sid="141" pm="."><plain>55–135), triglycerides (32.6 mg/dL; n.v. </plain></SENT>
<SENT sid="142" pm="."><plain>34–112), cholesterol (69.3 mg/dL; n.v. </plain></SENT>
<SENT sid="143" pm="."><plain>112–200), and LDL-cholesterol (14 mg/dL; n.v. </plain></SENT>
<SENT sid="144" pm="."><plain>63–129). </plain></SENT>
<SENT sid="145" pm="."><plain>PT, PTT, INR were normal. </plain></SENT>
<SENT sid="146" pm="."><plain>Because of the persistence of the biochemical alterations, a liver biopsy was obtained. </plain></SENT>
<SENT sid="147" pm="."><plain>Blood from the child and other members of the family was collected, after informed consent, for molecular analysis. </plain></SENT>
<SENT sid="148" pm="."><plain>The main biochemical parameters from the child and other family members are summarized in Table 3. </plain></SENT>
</text></p></sec><sec id="sec4dot2-ijms-18-02717"><title><text><SENT sid="149" pm="."><plain>4.2. </plain></SENT>
<SENT sid="150" pm="."><plain>Histology and Immunohistochemistry </plain></SENT>
</text></title><p><text><SENT sid="151" pm="."><plain>Part of the liver specimen was fixed in 10% formalin and embedded in paraffin. </plain></SENT>
<SENT sid="152" pm="."><plain>Four-micron-thick sections were stained with H.E., PAS, PAS after diastase (PAS-D), and Masson’s trichrome. </plain></SENT>
</text></p><p><text><SENT sid="153" pm="."><plain>Additional serial sections were stained by using the following antibodies against: fibrinogen (1:5000, polyclonal, Dako, Glostrup Municipality, Denmark), AAT (1:1000, ab9399, Abcam, Hong Kong), α-1-antichymotrypsin (ready to use, Dako), IgG (ready to use, Dako), APOB (1:1000, ab7616,). </plain></SENT>
</text></p><p><text><SENT sid="154" pm="."><plain>Double immunostaining for APOB and fibrinogen was carried out on a single tissue section. </plain></SENT>
</text></p><p><text><SENT sid="155" pm="."><plain>As controls, liver tissue sections from the Aguadilla patient were stained by omitting the primary antibodies. </plain></SENT>
<SENT sid="156" pm="."><plain>In addition, liver tissue sections from patients without hypofibrinogenemia or hypo-APOB-lipoproteinemia were processed and stained by using both primary antibodies. </plain></SENT>
</text></p></sec><sec id="sec4dot3-ijms-18-02717"><title><text><SENT sid="157" pm="."><plain>4.3. </plain></SENT>
<SENT sid="158" pm="."><plain>Electron Microscopy </plain></SENT>
</text></title><p><text><SENT sid="159" pm="."><plain>A small portion of the needle biopsy was fixed in 2.5% glutaraldheyde and embedded in Epon. </plain></SENT>
<SENT sid="160" pm="."><plain>Semithin sections were cut with a Leica Ultracut S ultramicrotome and stained with toluidine blue. </plain></SENT>
<SENT sid="161" pm="."><plain>Ultrathin sections were mounted on copper grids, stained with lead citrate and uranyl acetate, and analyzed with a Zeiss Leo 7000 transmission EM (Zeiss, Oberkochen, Germany). </plain></SENT>
</text></p></sec><sec id="sec4dot4-ijms-18-02717"><title><text><SENT sid="162" pm="."><plain>4.4. </plain></SENT>
<SENT sid="163" pm="."><plain>Molecular Genetics Analysis </plain></SENT>
</text></title><p><text><SENT sid="164" pm="."><plain>DNA was extracted, after informed consent, from the peripheral blood (QIAmp DNA Mini kit, Qiagen, Hilden, Germany). </plain></SENT>
<SENT sid="165" pm="."><plain>The mutation screening was done using polymerase chain reaction (PCR) amplification and DNA sequencing of coding exons and of all splice junctions of Fibrinogen α chain (FGA, NM_000508), Fibrinogen β chain (FGB, NM_005141), Fibrinogen γ chain (FGG, NM_000509), Apolipoprotein B (APOB, NM_000384) and Microsomal Triglyceride Transporter Protein (MTTP; NM_000253) genes. </plain></SENT>
</text></p></sec><sec id="sec4dot5-ijms-18-02717"><title><text><SENT sid="166" pm="."><plain>4.5. </plain></SENT>
<SENT sid="167" pm="."><plain>Structural Analysis </plain></SENT>
</text></title><p><text><SENT sid="168" pm="."><plain>The crystal structure with Protein Data Bank, PDB, code 1FZB was used for the molecular structure analysis of the covalently bound dimer of fragment D. The crystal structure of lipovitellin (PDB 1LSH) [23], that is the closest structurally characterized homologue of APOB, was shown together with the fibrinogen γ monomer (PDB 1FZB). </plain></SENT>
<SENT sid="170" pm="."><plain>The homology model of APOB was obtained from Richardson et al. [13]. </plain></SENT>
<SENT sid="171" pm="."><plain>The molecular rendering was made with Accelrys Discovery Studio. </plain></SENT>
<SENT sid="172" pm="."><plain>The hydrophobicity coloring was based on the hydrophobicity scale by Kyte and Doolittle. </plain></SENT>
</text></p></sec><sec id="sec4dot6-ijms-18-02717"><title><text><SENT sid="173" pm="."><plain>4.6. </plain></SENT>
<SENT sid="174" pm="."><plain>Retrospective Studies </plain></SENT>
</text></title><p><text><SENT sid="175" pm="."><plain>Histology, immunohistochemistry, and EM studies were redone in all FSD cases from the files, four cases carrying the Aguadilla mutation [10,11,14,17], one the Ankara [9], and one the Brescia mutation [3]. </plain></SENT>
<SENT sid="176" pm="."><plain>The study methodology was analogous to that of the proband. </plain></SENT>
<SENT sid="177" pm="."><plain>The available biochemical data from the case series are summarized in Table A. All cases were characterized by low plasma fibrinogen levels, and four Aguadilla cases and the Ankara case had concomitant hypo-APOB-lipoproteinemia. </plain></SENT>
<SENT sid="179" pm="."><plain>The levels of APOB lipoprotein were not available in the remaining two cases (one Aguadilla and one Brescia). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="CONCL"><sec id="sec5-ijms-18-02717"><title><text><SENT sid="180" pm="."><plain>5. </plain></SENT>
<SENT sid="181" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="182" pm="."><plain>In conclusion, this study has demonstrated that a scrupulous examination of routinely stained histological sections can allow the recognition of the elementary lesions underlying this intriguing phenomenon. </plain></SENT>
<SENT sid="183" pm="."><plain>Immunohistochemistry, EM, molecular genetics analysis, and 3-D protein structure analysis have contributed in confirming the light and electron microscopic findings and in unraveling the pathogenetic mechanisms. </plain></SENT>
</text></p><p><text><SENT sid="184" pm="."><plain>It would be interesting to check whether the phenomenon occurs also with other FSD mutations. </plain></SENT>
</text></p><p><text><SENT sid="185" pm="."><plain>Our report is expected to encourage pathologists to continue to report new cases of FSD and clinicians to design appropriate trials aimed to reduce the liver storage and plasma deficiency of the two proteins. </plain></SENT>
</text></p></sec></SecTag></body><back><notes><title>Aknowledgments</title><p>The Author wish to thank Federica Salutari, Marta Stefanelli, and Riccardo Mariani for the skilled technological assistance and Marco Tartaglia for constructive discussion and critical review of the manuscript. We would like to thank Martin K. Jones and Jere Segrest at Vanderbilt University for providing us with the structure file of the homology model of APOB described in their paper: Richardson, P.E., Manchekar, M.; Dashti, N.; Jones, M.K.; Beigneux, A.; Young, S.G.; Harvey, S.C.; Segrest, J.P. “Assembly of lipoprotein particles containing apolipoprotein-B: structural model for the nascent lipoprotein particle”, <italic>Biophys. J.</italic>
<bold>2005</bold>, <italic>88</italic>, 2789–2800.</p></notes><notes><title>Author Contributions</title><p>Francesco Callea and Emanuele Bellacchio designed the study and wrote the manuscript. Sinan Sari, Esendagli Guldal, Buket Dalgic, Gulen Akyol collected the clinical data and performed the liver biopsy of the proband. Tsuyoshi Sogo, Abdulrahman Al-Hussaini, Giuseppe Maggiore contributed with one case each. Isabella Giovannoni performed the molecular analysis. Paola Francalanci reviewed the histology of all cases. Renata Boldrini perfomed the electron microscopy. Emanuele Bellacchio conducted the protein structure analysis. Andrea Bartuli contributed to the discussion of APOB-lipoprotein metabolism and role.</p></notes><notes notes-type="COI-statement"><title>Conflict of interest</title><p>All authors indicated they have no potential conflicts of interest to disclose.</p></notes><SecTag type="REF"><ref-list><title>References</title><ref id="B1-ijms-18-02717"><text><SENT sid="186" pm="."><plain>1.CalleaF.De VosR.PinackatJ.Hereditary Hypofibrinogenemia with Hepatic Storage of Fibrinogen: A New Endoplasmic Reticulum Storage Disease, in Fibrinogen 2ElsevierAmsterdam, The Netherlands19877578 </plain></SENT>
</text></ref><ref id="B2-ijms-18-02717"><text><SENT sid="187" pm="."><plain>2.CalleaF.BrisigottiM.FabbrettiG.BoninoF.DesmetV.J.Hepatic endoplasmic reticulum storage diseasesLiver19921235736210.1111/j.1600-0676.1992.tb00589.x<?supplied-pmid 1470006?>1470006 </plain></SENT>
</text></ref><ref id="B3-ijms-18-02717"><text><SENT sid="188" pm="."><plain>3.BrennanS.O.WyattJ.MedicinaD.CalleaF.GeorgeP.M.Fibrinogen brescia: Hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a gamma284 Gly→Arg mutationAm. </plain></SENT>
<SENT sid="189" pm="."><plain>J. </plain></SENT>
<SENT sid="190" pm="."><plain>Pathol.200015718919610.1016/S0002-9440(10)64530-010880389 </plain></SENT>
</text></ref><ref id="B4-ijms-18-02717"><text><SENT sid="191" pm="."><plain>4.CalleaF.TortoraO.KojimaT.Hypofibrinogenemia and Fibrinogen Storage Disease, in Fibrinogen 3ElsevierAmsterdam, The Netherlands1988247250 </plain></SENT>
</text></ref><ref id="B5-ijms-18-02717"><text><SENT sid="192" pm="."><plain>5.BrennanS.O.MaghzalG.ShneiderB.L.GordonR.MagidM.S.GeorgeP.M.Novel fibrinogen gamma375 Arg→Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemiaHepatology20023665265810.1053/jhep.2002.35063<?supplied-pmid 12198657?>12198657 </plain></SENT>
</text></ref><ref id="B6-ijms-18-02717"><text><SENT sid="193" pm="."><plain>6.DibN.QuelinF.TernisienC.HanssM.MichalakS.De MazancourtP.RousseletM.C.CalesP.Fibrinogen angers with a new deletion (gamma GVYYQ 346–350) causes hypofibrinogenemia with hepatic storageJ. </plain></SENT>
<SENT sid="194" pm="."><plain>Thromb. </plain></SENT>
<SENT sid="195" pm="."><plain>Haemost.200751999200510.1111/j.1538-7836.2007.02713.x<?supplied-pmid 17883696?>17883696 </plain></SENT>
</text></ref><ref id="B7-ijms-18-02717"><text><SENT sid="196" pm="."><plain>7.BrennanS.O.DavisR.L.ConardK.SavoA.FuruyaK.N.Novel fibrinogen mutation gamma314Thr→Pro (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemiaLiver Int.2010301541154710.1111/j.1478-3231.2010.02312.x<?supplied-pmid 20666993?>20666993 </plain></SENT>
</text></ref><ref id="B8-ijms-18-02717"><text><SENT sid="197" pm="."><plain>8.AsseltaR.RobustoM.BraidottiP.PeyvandiF.NastasioS.D’AntigaL.PerisicV.N.MaggioreG.CacciaS.DugaS.Hepatic fibrinogen storage disease: Identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen gamma-moduleJ. </plain></SENT>
<SENT sid="198" pm="."><plain>Thromb. </plain></SENT>
<SENT sid="199" pm="."><plain>Haemost.2015131459146710.1111/jth.13021<?supplied-pmid 26039544?>26039544 </plain></SENT>
</text></ref><ref id="B9-ijms-18-02717"><text><SENT sid="200" pm="."><plain>9.CalleaF.GiovannoniI.SariS.AksuA.U.EsendaglyG.DalgicB.BoldriniR.AkyolG.FrancalanciP.BellacchioE.A novel fibrinogen gamma chain mutation (c.1096C&gt;G; p.His340Asp), fibrinogen Ankara, causing hypofibrinogenaemia and hepatic storagePathology20174953453710.1016/j.pathol.2017.03.007<?supplied-pmid 28673429?>28673429 </plain></SENT>
</text></ref><ref id="B10-ijms-18-02717"><text><SENT sid="201" pm="."><plain>10.SariS.YilmazG.GonulI.DalgicB.AkyolG.GiovannoniI.FrancalanciP.CalleaF.Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish childLiver Int.2015352501250510.1111/liv.12914<?supplied-pmid 26176881?>26176881 </plain></SENT>
</text></ref><ref id="B11-ijms-18-02717"><text><SENT sid="202" pm="."><plain>11.SogoT.NagasakaH.KomatsuH.InuiA.MiidaT.CalleaF.FrancalanciP.HiranoK.KitamuraH.YorifujiT.Fibrinogen storage disease caused by Aguadilla mutation presenting with hypobeta-lipoproteinemia and considerable liver diseaseJ. </plain></SENT>
<SENT sid="203" pm="."><plain>Pediatr. </plain></SENT>
<SENT sid="204" pm="."><plain>Gastroenterol. </plain></SENT>
<SENT sid="205" pm="."><plain>Nutr.20094913313610.1097/MPG.0b013e31817ed7ea<?supplied-pmid 19458552?>19458552 </plain></SENT>
</text></ref><ref id="B12-ijms-18-02717"><text><SENT sid="206" pm="."><plain>12.CalleaF.TardanicoR.FacchettiE.AlE.Pseudo ground-glass hepatocytes immunoreactive for fibrinogenOccurrence and significance in liver biopsies. </plain></SENT>
<SENT sid="207" pm="."><plain>Istiocitopatologia19857179183 </plain></SENT>
</text></ref><ref id="B13-ijms-18-02717"><text><SENT sid="208" pm="."><plain>13.RichardsonP.E.ManchekarM.DashtiN.JonesM.K.BeigneuxA.YoungS.G.HarveyS.C.SegrestJ.P.Assembly of lipoprotein particles containing apolipoprotein-B: Structural model for the nascent lipoprotein particleBiophys. </plain></SENT>
<SENT sid="209" pm="."><plain>J.2005882789280010.1529/biophysj.104.046235<?supplied-pmid 15653747?>15653747 </plain></SENT>
</text></ref><ref id="B14-ijms-18-02717"><text><SENT sid="210" pm="."><plain>14.FrancalanciP.SantorelliF.M.TaliniI.BoldriniR.DevitoR.CamasseiF.D.MaggioreG.CalleaF.Severe liver disease in early childhood due to fibrinogen storage and de novo gamma375Arg→Trp gene mutationJ. </plain></SENT>
<SENT sid="211" pm="."><plain>Pediatr.200614839639810.1016/j.jpeds.2005.10.007<?supplied-pmid 16615976?>16615976 </plain></SENT>
</text></ref><ref id="B15-ijms-18-02717"><text><SENT sid="212" pm="."><plain>15.Rubbia-BrandtL.Neerman-ArbezM.RougemontA.L.MaleP.J.SpahrL.Fibrinogen gamma375 arg→trp mutation (fibrinogen aguadilla) causes hereditary hypofibrinogenemia, hepatic endoplasmic reticulum storage disease and cirrhosisAm. </plain></SENT>
<SENT sid="213" pm="."><plain>J. </plain></SENT>
<SENT sid="214" pm="."><plain>Surg. </plain></SENT>
<SENT sid="215" pm="."><plain>Pathol.20063090691110.1097/01.pas.0000209848.59670.2c<?supplied-pmid 16819336?>16819336 </plain></SENT>
</text></ref><ref id="B16-ijms-18-02717"><text><SENT sid="216" pm="."><plain>16.PulsF.GoldschmidtI.BantelH.AgneC.BrockerV.DammrichM.LehmannU.BerrangJ.PfisterE.D.KreipeH.H.Autophagy-enhancing drug carbamazepine diminishes hepatocellular death in fibrinogen storage diseaseJ. </plain></SENT>
<SENT sid="217" pm="."><plain>Hepatol.20135962663010.1016/j.jhep.2013.05.018<?supplied-pmid 23707368?>23707368 </plain></SENT>
</text></ref><ref id="B17-ijms-18-02717"><text><SENT sid="218" pm="."><plain>17.Al-HussainiA.AltalhiA.El HagI.AlHussainiH.FrancalanciP.GiovannoniI.CalleaF.Hepatic fibrinogen storage disease due to the fibrinogen gamma375 Arg→Trp mutation “fibrinogen Aguadilla” is present in ArabsSaudi J. Gastroenterol.20142025526110.4103/1319-3767.136985<?supplied-pmid 25038212?>25038212 </plain></SENT>
</text></ref><ref id="B18-ijms-18-02717"><text><SENT sid="220" pm="."><plain>18.CasiniA.SokollikC.LukowskiS.W.LurzE.RieublandC.de MoerlooseP.Neerman-ArbezM.Hypofibrinogenemia and liver disease: A new case of Aguadilla fibrinogen and review of the literatureHaemophilia20152182082710.1111/hae.12719<?supplied-pmid 25990487?>25990487 </plain></SENT>
</text></ref><ref id="B19-ijms-18-02717"><text><SENT sid="221" pm="."><plain>19.ZhangM.H.KniselyA.S.WangN.L.GongJ.Y.WangJ.S.Fibrinogen storage disease in a Chinese boy with de novo fibrinogen Aguadilla mutation: Incomplete response to carbamazepine and ursodeoxycholic acidBMC Gastroenterol.2016169210.1186/s12876-016-0507-3<?supplied-pmid 27520927?>27520927 </plain></SENT>
</text></ref><ref id="B20-ijms-18-02717"><text><SENT sid="222" pm="."><plain>20.KaneJ.P.HavelR.J.Disorders of the Biogenesis and Secretion of Lipoproteins Containing the B ApolipoproteinsMcGraw-Hill ProfessionalLondon, UK2000 </plain></SENT>
</text></ref><ref id="B21-ijms-18-02717"><text><SENT sid="223" pm="."><plain>21.BurnettJ.R.ZhongS.JiangZ.G.HooperA.J.FisherE.A.McLeodR.S.ZhaoY.BarrettP.H.HegeleR.A.van BockxmeerF.M.Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemiaJ. </plain></SENT>
<SENT sid="224" pm="."><plain>Biol. </plain></SENT>
<SENT sid="225" pm="."><plain>Chem.2007282242702428310.1074/jbc.M702442200<?supplied-pmid 17588943?>17588943 </plain></SENT>
</text></ref><ref id="B22-ijms-18-02717"><text><SENT sid="226" pm="."><plain>22.SpraggonG.EverseS.J.DoolittleR.F.Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrinNature199738945546210.1038/38947<?supplied-pmid 9333233?>9333233 </plain></SENT>
</text></ref><ref id="B23-ijms-18-02717"><text><SENT sid="227" pm="."><plain>23.ThompsonJ.R.BanaszakL.J.Lipid-protein interactions in lipovitellinBiochemistry2002419398940910.1021/bi025674w<?supplied-pmid 12135361?>12135361 </plain></SENT>
</text></ref><ref id="B24-ijms-18-02717"><text><SENT sid="228" pm="."><plain>24.YaoZ.ZhouH.FigeysD.WangY.SundaramM.Microsome-associated lumenal lipid droplets in the regulation of lipoprotein secretionCurr. </plain></SENT>
<SENT sid="229" pm="."><plain>Opin. </plain></SENT>
<SENT sid="230" pm="."><plain>Lipidol.20132416017010.1097/MOL.0b013e32835aebe7<?supplied-pmid 23123764?>23123764 </plain></SENT>
</text></ref><ref id="B25-ijms-18-02717"><text><SENT sid="231" pm="."><plain>25.MedicinaD.FabbrettiG.BrennanS.O.GeorgeP.M.KudrykB.CalleaF.Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver diseaseAnn. </plain></SENT>
<SENT sid="232" pm="."><plain>N. </plain></SENT>
<SENT sid="233" pm="."><plain>Y. </plain></SENT>
<SENT sid="234" pm="."><plain>Acad. </plain></SENT>
<SENT sid="235" pm="."><plain>Sci.200193652252510.1111/j.1749-6632.2001.tb03538.x<?supplied-pmid 11460509?>11460509 </plain></SENT>
</text></ref><ref id="B26-ijms-18-02717"><text><SENT sid="236" pm="."><plain>26.RedmanC.M.XiaH.Fibrinogen biosynthesis. </plain></SENT>
<SENT sid="237" pm="."><plain>Assembly, intracellular degradation, and association with lipid synthesis and secretionAnn. </plain></SENT>
<SENT sid="238" pm="."><plain>N. </plain></SENT>
<SENT sid="239" pm="."><plain>Y. </plain></SENT>
<SENT sid="240" pm="."><plain>Acad. </plain></SENT>
<SENT sid="241" pm="."><plain>Sci.200193648049510.1111/j.1749-6632.2001.tb03535.x<?supplied-pmid 11460506?>11460506 </plain></SENT>
</text></ref><ref id="B27-ijms-18-02717"><text><SENT sid="242" pm="."><plain>27.KruseK.B.DearA.KaltenbrunE.R.CrumB.E.GeorgeP.M.BrennanS.O.McCrackenA.A.Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: An explanation for liver diseaseAm. </plain></SENT>
<SENT sid="243" pm="."><plain>J. </plain></SENT>
<SENT sid="244" pm="."><plain>Pathol.20061681299130810.2353/ajpath.2006.051097<?supplied-pmid 16565503?>16565503 </plain></SENT>
</text></ref><ref id="B28-ijms-18-02717"><text><SENT sid="245" pm="."><plain>28.ShelnessG.S.IngramM.F.HuangX.F.DeLozierJ.A.Apolipoprotein B in the rough endoplasmic reticulum: Translation, translocation and the initiation of lipoprotein assemblyJ. </plain></SENT>
<SENT sid="246" pm="."><plain>Nutr.1999129Suppl. </plain></SENT>
<SENT sid="247" pm="."><plain>2S456S462S10064309 </plain></SENT>
</text></ref><ref id="B29-ijms-18-02717"><text><SENT sid="248" pm="."><plain>29.FisherE.LakeE.McLeodR.S.Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretionJ. </plain></SENT>
<SENT sid="249" pm="."><plain>Biomed. </plain></SENT>
<SENT sid="250" pm="."><plain>Res.201428178193<?supplied-pmid 25013401?>25013401 </plain></SENT>
</text></ref><ref id="B30-ijms-18-02717"><text><SENT sid="251" pm="."><plain>30.MaggioreG.NastasioS.SciveresM.Long-term outcome of liver disease-related fibrinogen aguadilla storage disease in a childJ. </plain></SENT>
<SENT sid="252" pm="."><plain>Pediatr. </plain></SENT>
<SENT sid="253" pm="."><plain>Gastroenterol. </plain></SENT>
<SENT sid="254" pm="."><plain>Nutr.20115369910.1097/MPG.0b013e318232c477<?supplied-pmid 21866059?>21866059 </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-group><SecTag type="FIG"><fig id="ijms-18-02717-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p><text><SENT sid="255" pm="."><plain>Liver tissue sections from the proband Aguadilla case (A) Hematoxilin and Eosin (HE) 100×; the microphotograph shows hepatocytes with plenty of round eosinophilic cytoplasmic inclusions surrounded by a clear halo. </plain></SENT>
<SENT sid="256" pm="."><plain>Individual inclusions contain empty vacuoles that can be single or multiple (arrows); (B) EM 2500×; the electronmicrophotograph from the same case shows four hepatocytes with dilated cisternae of the ER filled up with tubular curved bundles corresponding to fibrinogen. </plain></SENT>
<SENT sid="257" pm="."><plain>Lipid droplets are present within the fibrinogen. </plain></SENT>
<SENT sid="258" pm="."><plain>The cytosol contains lipid inclusions of variable size (microsteatosis). </plain></SENT>
<SENT sid="259" pm="."><plain>A color line draws the hepatocytes shapes; (C) Immunostaining of a serial section from the same case stained with an anti-APOB antibody, 100×, showing positivity in the form of single or multiple inclusions. </plain></SENT>
<SENT sid="260" pm="."><plain>Positivity is strong in the periphery of the droplets (arrows), whilst the central core remains negative; (D) EM 12,000×; a large dilated cisterna of ER containing fingerprint-like tubular structures filling up the entire lumen. </plain></SENT>
<SENT sid="261" pm="."><plain>A few small lipid droplets are located within the tubular structures; (E) Double immunostaining of a serial section from the same case, using an anti-fibrinogen and an anti-APOB antibodies sequentially (1000×). </plain></SENT>
<SENT sid="262" pm="."><plain>Fibrinogen inclusions fill up the entire hepatocyte cytoplasm and are stained in red; the lipid droplets containing APOB are stained in dark brown. </plain></SENT>
<SENT sid="263" pm="."><plain>The latter can be single or multiple, and the positivity is located at the periphery of the droplets (arrows); (F) EM 18,000×; fibrinogen Brescia case. </plain></SENT>
<SENT sid="264" pm="."><plain>The electronmicrophotograph shows a high magnification of a dilated cisterna of ER filled up with fingerprint-like tubular structures arranged in curved bundles. </plain></SENT>
<SENT sid="265" pm="."><plain>The fibrinogen inclusion contains two large lipid droplets. </plain></SENT>
</text></p></caption><graphic xlink:href="ijms-18-02717-g001"/></fig></SecTag><SecTag type="FIG"><fig id="ijms-18-02717-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p><text><SENT sid="266" pm="."><plain>Crystal structure of the covalently bound dimer of fragment D (double-D). </plain></SENT>
<SENT sid="267" pm="."><plain>(A) Molecular surface representation of the fibrinogen chains composing the fragment D dimer (PDB 1FZB); (B) The two fibrinogen gamma chains arranged head to head as in the fragment D dimer and after rotations of 90° are shown to highlight the regions of mutual interaction (areas enclosed by the red, dotted lines). </plain></SENT>
<SENT sid="268" pm="."><plain>Molecular surfaces are colored according to the residue hydrophobicity. </plain></SENT>
<SENT sid="269" pm="."><plain>The positions of the residues mutated in Fibrinogen Ankara (H340), Aguadilla (R375), and Brescia (G284) are indicated. </plain></SENT>
<SENT sid="270" pm="."><plain>The covalent link between the gamma chains is schematized by the gray, dotted line. </plain></SENT>
</text></p></caption><graphic xlink:href="ijms-18-02717-g002"/></fig></SecTag><SecTag type="FIG"><fig id="ijms-18-02717-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p><text><SENT sid="271" pm="."><plain>Exposed hydrophobic region in the unpolymerized fibrinogen gamma chain as a potential site for abnormal interactions with APOB. </plain></SENT>
<SENT sid="272" pm="."><plain>A fibrinogen γ monomer (PDB 1FZB) is shown together with the homology model of APOB with bound lipids [13] and the crystal structure of the closest structurally characterized homologue of the latter, lipovitellin (PDB 1LSH). </plain></SENT>
<SENT sid="273" pm="."><plain>Molecular surfaces are colored according to the residue hydrophobicity. </plain></SENT>
<SENT sid="274" pm="."><plain>The partial lipid structures bound to lipovitellin are present in the crystal structure. </plain></SENT>
<SENT sid="275" pm="."><plain>A failure in fibrinogen polymerization leaves exposed a large hydrophobic region in the gamma chains, which might give rise to undue interactions with lipids and with the hydrophobic regions of APOB and other proteins. </plain></SENT>
</text></p></caption><graphic xlink:href="ijms-18-02717-g003"/></fig></SecTag><SecTag type="TABLE"><table-wrap id="ijms-18-02717-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-18-02717-t001_Table 1</object-id><label>Table 1</label><caption><p><text><SENT sid="276" pm="."><plain>Ethnic, molecular genetics, biochemical, and morphological findings in seven fibrinogen storage disease (FSD) cases. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>Case </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>Age </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>Sex </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>Ethn </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>Mutation </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>Fibrinogen (Normal Value-n.v. </plain></SENT>
<SENT sid="283" pm="."><plain>200–400) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>APO-B </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>TChol </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>LDLChol </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>Triglyc </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>Lipid Inclusion </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>Liver Path </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>1 Proband </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>2 y </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>Turkey </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>74 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="296" pm="."><plain>&lt;24.5 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="297" pm="."><plain>69.3 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="298" pm="."><plain>14 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="299" pm="."><plain>32.6 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="300" pm="."><plain>+++ </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="301" pm="."><plain>Portal and septal fibrosis </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>5 y </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>Turkey </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>48 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>&lt;22.1 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>69 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>37 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>28 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>++ </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>4 y </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>Italy </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>43 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>++ </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="325" pm="."><plain>Septal fibrosis </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="326" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="327" pm="."><plain>2 y </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="328" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="329" pm="."><plain>Japan </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="330" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>37.6 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>22 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>76 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>32 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>45 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>+++ </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>Early cirrhosis </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>5 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>3 y </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>Saudi A. </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>89 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>+++ </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>6 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>5.5 y </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>Turkey </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="354" pm="."><plain>Ankara </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="355" pm="."><plain>49 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="356" pm="."><plain>75 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="357" pm="."><plain>169 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="358" pm="."><plain>99 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>100 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>++ </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>7 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>49 y </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>Italy </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>Brescia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>20 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>+++ </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>Cirrhosis </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="ijms-18-02717-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-18-02717-t002_Table 2</object-id><label>Table 2</label><caption><p><text><SENT sid="374" pm="."><plain>Literature review for confirmed cases of FGG mutations. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>Reference </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>Mutant Fibrinogen </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>Age (Year) </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>Gender </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>Clinical Presentation </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>Liver Disease </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>[3] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="382" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="383" pm="."><plain>Brescia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="384" pm="."><plain>64 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="385" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="386" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="387" pm="."><plain>Severe </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="388" pm="."><plain>6 adult family members </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="389" pm="."><plain>5 F &amp; 1 M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="390" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="391" pm="."><plain>[5] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="392" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="393" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="394" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="395" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="396" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="397" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="398" pm="."><plain>Sibling </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="399" pm="."><plain>7 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="400" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="401" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="402" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="403" pm="."><plain>Father </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="404" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="405" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="406" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="407" pm="."><plain>[14] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="408" pm="."><plain>Index </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="409" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="410" pm="."><plain>6 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="411" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="412" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="413" pm="."><plain>Severe </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="414" pm="."><plain>[15] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="415" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="416" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="417" pm="."><plain>61 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="418" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="419" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="420" pm="."><plain>Severe </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="421" pm="."><plain>Son </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="422" pm="."><plain>28 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="423" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="424" pm="."><plain>Normal ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="425" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="426" pm="."><plain>Son </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="427" pm="."><plain>22 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="428" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="429" pm="."><plain>Normal ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="430" pm="."><plain>[6] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="431" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="432" pm="."><plain>Anger </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="433" pm="."><plain>35 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="434" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="435" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="436" pm="."><plain>Severe </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="437" pm="."><plain>3 adult family members </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="438" pm="."><plain>2 F &amp; 1 M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="439" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="440" pm="."><plain>[11] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="441" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="442" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="443" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="444" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="445" pm="."><plain>Elevated ALT/AST and hypo-β-lipoproteinemia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="446" pm="."><plain>Moderate–Severe </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="447" pm="."><plain>Father </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="448" pm="."><plain>Normal ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="449" pm="."><plain>[7] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="450" pm="."><plain>Index </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="451" pm="."><plain>Al duPont </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="452" pm="."><plain>4 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="453" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="454" pm="."><plain>Elevated ALT/AST and mild coagulopathy </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="455" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="456" pm="."><plain>[16] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="457" pm="."><plain>Index </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="458" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="459" pm="."><plain>6 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="460" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="461" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="462" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="463" pm="."><plain>[16] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="464" pm="."><plain>Index </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="465" pm="."><plain>Brescia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="466" pm="."><plain>5 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="467" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="468" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="469" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="470" pm="."><plain>[17] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="471" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="472" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="473" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="474" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="475" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="476" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="477" pm="."><plain>Father </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="478" pm="."><plain>42 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="479" pm="."><plain>[10] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="480" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="481" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="482" pm="."><plain>7 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="483" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="484" pm="."><plain>Elevated ALT/AST and hypo-β-lipoproteinemia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="485" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="486" pm="."><plain>Mother </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="487" pm="."><plain>33 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="488" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="489" pm="."><plain>Normal ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="490" pm="."><plain>Brother </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="491" pm="."><plain>11 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="492" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="493" pm="."><plain>Normal ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="494" pm="."><plain>Sister I </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="495" pm="."><plain>9 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="496" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="497" pm="."><plain>Normal ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="498" pm="."><plain>Sister II </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="499" pm="."><plain>5 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="500" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="501" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="502" pm="."><plain>[18] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="503" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="504" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="505" pm="."><plain>4.6 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="506" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="507" pm="."><plain>Fibrinogen = 70 mg/dL Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="508" pm="."><plain>NA </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="509" pm="."><plain>Mother </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="510" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="511" pm="."><plain>NA </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="512" pm="."><plain>Grandmother </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="513" pm="."><plain>Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="514" pm="."><plain>NA </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="515" pm="."><plain>[8] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="516" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="517" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="518" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="519" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="520" pm="."><plain>Fibrinogen (immunological 117 (n.v. </plain></SENT>
<SENT sid="521" pm="."><plain>160–400) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="522" pm="."><plain>Normal Liver </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="523" pm="."><plain>Mother </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="524" pm="."><plain>Maternal grandfather </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="525" pm="."><plain>[8] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="526" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="527" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="528" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="529" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="530" pm="."><plain>Fibrinogen 66 mg/dL Elevated ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="531" pm="."><plain>Normal Liver </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="532" pm="."><plain>Mother </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="533" pm="."><plain>Brother </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="534" pm="."><plain>[9] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="535" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="536" pm="."><plain>Ankara </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="537" pm="."><plain>5.5 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="538" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="539" pm="."><plain>Elevated ALT/AST Hypo-APOB-lipoproteinemia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="540" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="541" pm="."><plain>Father </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="542" pm="."><plain>[19] </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="543" pm="."><plain>Index </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="544" pm="."><plain>Aguadilla (de novo) </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="545" pm="."><plain>2 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="546" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="547" pm="."><plain>Fibrinogen 29mg/dL </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="548" pm="."><plain>Portal fibrosis and mild hepatitis </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="549" pm="."><plain>Present Case </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text></text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="550" pm="."><plain>Index </plain></SENT>
</text></td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><text><SENT sid="551" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="552" pm="."><plain>3 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="553" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="554" pm="."><plain>Elevated ALT/AST hypo-APOB-lipoprotereinemia </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="555" pm="."><plain>Mild </plain></SENT>
</text></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="556" pm="."><plain>Mother </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="557" pm="."><plain>24 </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="558" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="559" pm="."><plain>Normal ALT/AST </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="560" pm="."><plain>NA </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="ijms-18-02717-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-18-02717-t003_Table 3</object-id><label>Table 3</label><caption><p><text><SENT sid="561" pm="."><plain>Proband’s family studies: main clinical, biochemical, and molecular genetics results. </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text></text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="562" pm="."><plain>Proband </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="563" pm="."><plain>Sibling </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="564" pm="."><plain>Mother </plain></SENT>
</text></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="565" pm="."><plain>Father </plain></SENT>
</text></th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="566" pm="."><plain>Age </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="567" pm="."><plain>2 years </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="568" pm="."><plain>4 years </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="569" pm="."><plain>24 years </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="570" pm="."><plain>36 years </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="571" pm="."><plain>Gender </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="572" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="573" pm="."><plain>M </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="574" pm="."><plain>F </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="575" pm="."><plain>M </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="576" pm="."><plain>Hepatomegaly </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="577" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="578" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="579" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="580" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="581" pm="."><plain>Splenomegaly </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="582" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="583" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="584" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="585" pm="."><plain>- </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="586" pm="."><plain>AST, U/L (n.v. </plain></SENT>
<SENT sid="587" pm="."><plain>20–60) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="588" pm="."><plain>77 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="589" pm="."><plain>25 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="590" pm="."><plain>15 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="591" pm="."><plain>30 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="592" pm="."><plain>ALT, U/L (n.v. </plain></SENT>
<SENT sid="593" pm="."><plain>5–45) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="594" pm="."><plain>151 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="595" pm="."><plain>13 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="596" pm="."><plain>13 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="597" pm="."><plain>47 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="598" pm="."><plain>GGT, U/L (n.v. </plain></SENT>
<SENT sid="599" pm="."><plain>5–32) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="600" pm="."><plain>67 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="601" pm="."><plain>10 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="602" pm="."><plain>10 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="603" pm="."><plain>35 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="604" pm="."><plain>ALP, U/L (n.v. </plain></SENT>
<SENT sid="605" pm="."><plain>145–420) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="606" pm="."><plain>316 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="607" pm="."><plain>216 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="608" pm="."><plain>83 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="609" pm="."><plain>67 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="610" pm="."><plain>Triglyceride, mg/dL (n.v. </plain></SENT>
<SENT sid="611" pm="."><plain>34–112) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="612" pm="."><plain>32.6 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="613" pm="."><plain>75 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="614" pm="."><plain>39.8 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="615" pm="."><plain>282.6 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="616" pm="."><plain>Cholesterol, mg/dL (n.v. </plain></SENT>
<SENT sid="617" pm="."><plain>112–200) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="618" pm="."><plain>69.3 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="619" pm="."><plain>176.8 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="620" pm="."><plain>167.7 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="621" pm="."><plain>245.7 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="622" pm="."><plain>LDL-Cholesterol, mg/dL (n.v. </plain></SENT>
<SENT sid="623" pm="."><plain>63–129) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="624" pm="."><plain>14 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="625" pm="."><plain>103 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="626" pm="."><plain>95 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="627" pm="."><plain>152 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="628" pm="."><plain>APOB mg/dL (n.v. </plain></SENT>
<SENT sid="629" pm="."><plain>55–135) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="630" pm="."><plain>&lt;24.5 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="631" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="632" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="633" pm="."><plain>128 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="634" pm="."><plain>PT, s. (n.v. </plain></SENT>
<SENT sid="636" pm="."><plain>12.1–14.5) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="637" pm="."><plain>14.8 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="638" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="639" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="640" pm="."><plain>11.3 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="641" pm="."><plain>INR (n.v. </plain></SENT>
<SENT sid="642" pm="."><plain>0.92–1.14) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="643" pm="."><plain>1.27 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="644" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="645" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="646" pm="."><plain>0.95 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="647" pm="."><plain>PTT, s. 1 (n.v. </plain></SENT>
<SENT sid="649" pm="."><plain>25–34) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="650" pm="."><plain>26 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="651" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="652" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="653" pm="."><plain>25 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="654" pm="."><plain>Fibrinogen, mg/dL (n.v. </plain></SENT>
<SENT sid="655" pm="."><plain>200–400) </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="656" pm="."><plain>74 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="657" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="658" pm="."><plain>140 </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="659" pm="."><plain>292 </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><text><SENT sid="660" pm="."><plain>Liver biopsy </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="661" pm="."><plain>+ </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="662" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="663" pm="."><plain>NA </plain></SENT>
</text></td><td align="center" valign="middle" rowspan="1" colspan="1"><text><SENT sid="664" pm="."><plain>NA </plain></SENT>
</text></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="665" pm="."><plain>Molecular analysis </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="666" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="667" pm="."><plain>- </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="668" pm="."><plain>Aguadilla </plain></SENT>
</text></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><text><SENT sid="669" pm="."><plain>- </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p>n.v. = normal value; AST, aspartate transferase; ALT, alanine amino transferase; GGT, gamma glutamil transpeptidase; ALP, alkaline phosphatase; PT, prothrombin time; INR, international normalised ratio; PTT, thrombin partial time; NA, not assessed.</p></fn></table-wrap-foot></table-wrap></SecTag></floats-group></article>
